{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "green synthesis", "medicinal plants", "nanotechnology", "theranostic NPs"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30405389", "DateRevised": {"Year": "2023", "Month": "10", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "10", "Day": "23"}], "Language": ["eng"], "ELocationID": ["284", "10.3389/fnagi.2018.00284"], "Journal": {"ISSN": "1663-4365", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2018"}}, "Title": "Frontiers in aging neuroscience", "ISOAbbreviation": "Front Aging Neurosci"}, "ArticleTitle": "Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer's Disease: Present Status and Future Opportunities.", "Pagination": {"StartPage": "284", "MedlinePgn": "284"}, "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is characterized by cognitive inability manifested due to the accumulation of \u03b2-amyloid, formation of hyper phosphorylated neurofibrillary tangles, and a malfunctioned cholinergic system. The degeneration integrity of the neuronal network can appear long after the onset of the disease. Nanotechnology-based interventions have opened an exciting area via theranostics of AD in terms of tailored nanomedicine, which are able to target and deliver drugs across the blood-brain barrier (BBB). The exciting interface existing between medicinal plants and nanotechnology is an emerging marvel in medicine, which has delivered promising results in the treatment of AD. In order to assess the potential applications of the medicinal plants, their derived components, and various nanomedicinal approaches, a review of literature was deemed as necessary. In the present review, numerous phytochemicals and various feats in nanomedicine for the treatment of AD have been discussed mechanistically for the first time. Furthermore, recent trends in nanotechnology such as green synthesis of metal nanoparticles with reference to the treatment of AD have been elaborated. Foreseeing the recent progress, we hope that the interface of medicinal plants and nanotechnology will lead to highly effective theranostic strategies for the treatment of AD in the near future."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan."}, {"Identifier": [], "Affiliation": "National Institute of Lasers and Optronics, Pakistan Atomic Energy Commission, Islamabad, Pakistan."}, {"Identifier": [], "Affiliation": "CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China."}], "LastName": "Ovais", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Lasers and Optronics, Pakistan Atomic Energy Commission, Islamabad, Pakistan."}, {"Identifier": [], "Affiliation": "Department of Pharmacy, University of Peshawar, Peshawar, Pakistan."}], "LastName": "Zia", "ForeName": "Nashmia", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life Sciences, King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia."}], "LastName": "Ahmad", "ForeName": "Irshad", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Eastern Medicine and Surgery, Qarshi University, Lahore, Pakistan."}], "LastName": "Khalil", "ForeName": "Ali Talha", "Initials": "AT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Lasers and Optronics, Pakistan Atomic Energy Commission, Islamabad, Pakistan."}], "LastName": "Raza", "ForeName": "Abida", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Malakand, Chakdara, Pakistan."}], "LastName": "Ayaz", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Malakand, Chakdara, Pakistan."}, {"Identifier": [], "Affiliation": "Department of Life Sciences and Chemistry, Faculty of Health, Jacobs University Bremen, Bremen, Germany."}], "LastName": "Sadiq", "ForeName": "Abdul", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Malakand, Chakdara, Pakistan."}], "LastName": "Ullah", "ForeName": "Farhat", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan."}, {"Identifier": [], "Affiliation": "Department of Eastern Medicine and Surgery, Qarshi University, Lahore, Pakistan."}, {"Identifier": [], "Affiliation": "Pakistan Academy of Sciences, Islamabad, Pakistan."}], "LastName": "Shinwari", "ForeName": "Zabta Khan", "Initials": "ZK"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Aging Neurosci", "NlmUniqueID": "101525824", "ISSNLinking": "1663-4365"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Aalinkeel R., Kutscher H. L., Singh A., Cwiklinski K., Khechen N., Schwartz S. A., et al. (2018). Neuroprotective effects of a biodegradable poly (lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential nanotherapy for Alzheimer\u2019s disease? J. Drug Target. 26 182\u2013193. 10.1080/1061186X.2017.1354002", "ArticleIdList": ["10.1080/1061186X.2017.1354002", "28697660"]}, {"Citation": "Abbott N. J., Patabendige A. A., Dolman D. E., Yusof S. R., Begley D. J. (2010). Structure and function of the blood\u2013brain barrier. Neurobiol. Dis. 37 13\u201325. 10.1016/j.nbd.2009.07.030", "ArticleIdList": ["10.1016/j.nbd.2009.07.030", "19664713"]}, {"Citation": "Agarwa P., Sharma B., Fatima A., Jain S. K. (2014). An update on Ayurvedic herb Convolvulus pluricaulis Choisy. Asian Pac. J. Trop. Biomed. 4 245\u2013252. 10.1016/S2221-1691(14)60240-9", "ArticleIdList": ["10.1016/S2221-1691(14)60240-9", "PMC3868798", "25182446"]}, {"Citation": "Aggarwal B. B., Sung B. (2009). Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol. Sci. 30 85\u201394. 10.1016/j.tips.2008.11.002", "ArticleIdList": ["10.1016/j.tips.2008.11.002", "19110321"]}, {"Citation": "Agnihotri S. A., Mallikarjuna N. N., Aminabhavi T. M. (2004). Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J. Control. Release 100 5\u201328. 10.1016/j.jconrel.2004.08.010", "ArticleIdList": ["10.1016/j.jconrel.2004.08.010", "15491807"]}, {"Citation": "Aguiar S., Borowski T. (2013). Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. 16 313\u2013326. 10.1089/rej.2013.1431", "ArticleIdList": ["10.1089/rej.2013.1431", "PMC3746283", "23772955"]}, {"Citation": "Agyare E. K., Curran G. L., Ramakrishnan M., Caroline C. Y., Poduslo J. F., Kandimalla K. K. (2008). Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer\u2019s disease and cerebral amyloid angiopathy. Pharm. Res. 25 2674\u20132684. 10.1007/s11095-008-9688-y", "ArticleIdList": ["10.1007/s11095-008-9688-y", "PMC3766361", "18712585"]}, {"Citation": "Ahlemeyer B., Krieglstein J. (2003). Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer\u2019s disease. Pharmacopsychiatry 36 8\u201314. 10.1055/s-2003-40454", "ArticleIdList": ["10.1055/s-2003-40454", "13130383"]}, {"Citation": "Ahmad S., Ullah F., Sadiq A., Ayaz M., Imran M., Ali I., et al. (2016). Chemical composition, antioxidant and anticholinesterase potentials of essential oil of Rumex hastatus D. Don collected from the North West of Pakistan. BMC Complement. Alternat. Med. 16:29. 10.1186/s12906-016-0998-z", "ArticleIdList": ["10.1186/s12906-016-0998-z", "PMC4727414", "26810212"]}, {"Citation": "Akhondzadeh S., Sabet M. S., Harirchian M. H., Togha M., Cheraghmakani H., Razeghi S., et al. (2010). A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer\u2019s disease. Psychopharmacology 207 637\u2013643. 10.1007/s00213-009-1706-1", "ArticleIdList": ["10.1007/s00213-009-1706-1", "19838862"]}, {"Citation": "Akram M., Nawaz A. (2017). Effects of medicinal plants on Alzheimer\u2019s disease and memory deficits. Neural Regen. Res. 12 660\u2013670. 10.4103/1673-5374.205108", "ArticleIdList": ["10.4103/1673-5374.205108", "PMC5436367", "28553349"]}, {"Citation": "Ali M., Khan T., Fatima K., Ali Q. U. A., Ovais M., Khalil A. T., et al. (2018). Selected hepatoprotective herbal medicines: evidence from ethnomedicinal applications, animal models, and possible mechanism of actions. Phytother. Res. 32 199\u2013215. 10.1002/ptr.5957", "ArticleIdList": ["10.1002/ptr.5957", "PMC7167792", "29047177"]}, {"Citation": "Ali M., Muhammad S., Shah M. R., Khan A., Rashid U., Farooq U., et al. (2017). Neurologically potent molecules from Crataegus oxyacantha; isolation, anticholinesterase inhibition, and molecular docking. Front. Pharmacol. 8:327. 10.3389/fphar.2017.00327", "ArticleIdList": ["10.3389/fphar.2017.00327", "PMC5461367", "28638340"]}, {"Citation": "Ali Y. O., Bradley G., Lu H.-C. (2017). Screening with an NMNAT2-MSD platform identifies small molecules that modulate NMNAT2 levels in cortical neurons. Sci. Rep. 7:43846. 10.1038/srep43846", "ArticleIdList": ["10.1038/srep43846", "PMC5358788", "28266613"]}, {"Citation": "Alzheimer\u2019s and Association (2017). 2017 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 13 325\u2013373. 10.1016/j.jalz.2017.02.001", "ArticleIdList": ["10.1016/j.jalz.2017.02.001"]}, {"Citation": "Anwar A., Ovais M., Khan A., Raza A. (2017). Docetaxel-loaded solid lipid nanoparticles: a novel drug delivery system. IET Nanobiotechnol. 11 621\u2013629. 10.1049/iet-nbt.2017.0001", "ArticleIdList": ["10.1049/iet-nbt.2017.0001"]}, {"Citation": "Arumugam K., Subramanian G., Mallayasamy S., Averineni R., Reddy M., Udupa N. (2008). A study of rivastigmine liposomes for delivery into the brain through intranasal route. Acta Pharm. 58 287\u2013297. 10.2478/v10007-008-0014-3", "ArticleIdList": ["10.2478/v10007-008-0014-3", "19103565"]}, {"Citation": "Asgarpanah J., Kazemivash N. (2012). Phytochemistry and pharmacologic properties of Myristica fragrans hoyutt: a review. Afr. J. Biotechnol. 11 12787\u201312793. 10.5897/AJB12.1043", "ArticleIdList": ["10.5897/AJB12.1043"]}, {"Citation": "Ayaz M., Junaid M., Ahmed J., Ullah F., Sadiq A., Ahmad S., et al. (2014). Phenolic contents, antioxidant and anticholinesterase potentials of crude extract, subsequent fractions and crude saponins from Polygonum hydropiper L. BMC Complement. Altern. Med. 14:145. 10.1186/1472-6882-14-145", "ArticleIdList": ["10.1186/1472-6882-14-145", "PMC4018186", "24884823"]}, {"Citation": "Ayaz M., Junaid M., Ullah F., Sadiq A., Khan M. A., Ahmad W., et al. (2015). Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: a preliminary anti-Alzheimer\u2019s study. Lipids Health Dis. 14:141. 10.1186/s12944-015-0145-8", "ArticleIdList": ["10.1186/s12944-015-0145-8", "PMC4632677", "26530857"]}, {"Citation": "Ayaz M., Junaid M., Ullah F., Sadiq A., Ovais M., Ahmad W., et al. (2016). Chemical profiling, antimicrobial and insecticidal evaluations of Polygonum hydropiper L. BMC Complement. Altern. Med. 16:502. 10.1186/s12906-016-1491-4", "ArticleIdList": ["10.1186/s12906-016-1491-4", "PMC5139080", "27919287"]}, {"Citation": "Ayaz M., Junaid M., Ullah F., Sadiq A., Shahid M., Ahmad W., et al. (2017a). GC-MS analysis and gastroprotective evaluations of crude extracts, isolated saponins, and essential oil from Polygonum hydropiper L. Front. Chem. 5:58. 10.3389/fchem.2017.00058", "ArticleIdList": ["10.3389/fchem.2017.00058", "PMC5539133", "28824906"]}, {"Citation": "Ayaz M., Junaid M., Ullah F., Subhan F., Sadiq A., Ali G., et al. (2017b). Anti-Alzheimer\u2019s studies on \u03b2-sitosterol isolated from Polygonum hydropiper L. Front. Pharmacol. 8:697 10.3389/fphar.2017.00697", "ArticleIdList": ["10.3389/fphar.2017.00697", "PMC5635809", "29056913"]}, {"Citation": "Ayaz M., Sadiq A., Junaid M., Ullah F., Subhan F., Ahmed J. (2017c). Neuroprotective and anti-aging potentials of essential oils from aromatic and medicinal plants. Front. Aging Neurosci. 9:168 10.3389/fnagi.2017.00168", "ArticleIdList": ["10.3389/fnagi.2017.00168", "PMC5447774", "28611658"]}, {"Citation": "Ayaz M., Subhan F., Sadiq A., Ullah F., Ahmed J., Sewell R. (2017d). Cellular efflux transporters and the potential role of natural products in combating efflux mediated drug resistance. Front. Biosci. 22 732\u2013756. 10.2741/4513", "ArticleIdList": ["10.2741/4513", "27814643"]}, {"Citation": "Azria D., Blanquer S., Verdier J.-M., Belamie E. (2017). Nanoparticles as contrast agents for brain nuclear magnetic resonance imaging in Alzheimer\u2019s disease diagnosis. J. Mater. Chem. B 5 7216\u20137237. 10.1039/C7TB01599B", "ArticleIdList": ["10.1039/C7TB01599B", "32264173"]}, {"Citation": "Balducci C., Mancini S., Minniti S., La Vitola P., Zotti M., Sancini G., et al. (2014). Multifunctional liposomes reduce brain \u03b2-amyloid burden and ameliorate memory impairment in Alzheimer\u2019s disease mouse models. J. Neurosci. 34 14022\u201314031. 10.1523/JNEUROSCI.0284-14.2014", "ArticleIdList": ["10.1523/JNEUROSCI.0284-14.2014", "PMC4198543", "25319699"]}, {"Citation": "Barabadi H., Alizadeh A., Ovais M., Ahmadi A., Shinwari Z. K., Saravanan M. (2017a). Efficacy of green nanoparticles against cancerous and normal cell lines: a systematic review and meta-analysis. IET Nanobiotechnol. 12 377\u2013391. 10.1049/iet-nbt.2017.0120", "ArticleIdList": ["10.1049/iet-nbt.2017.0120", "PMC8676322", "29768219"]}, {"Citation": "Barabadi H., Ovais M., Shinwari Z. K., Saravanan M. (2017b). Anti-cancer green bionanomaterials: present status and future prospects. Green Chem. Lett. Rev. 10 285\u2013314. 10.1080/17518253.2017.1385856", "ArticleIdList": ["10.1080/17518253.2017.1385856"]}, {"Citation": "Baum L., Lam C. W. K., Cheung S. K.-K., Kwok T., Lui V., Tsoh J., et al. (2008). Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J. Clin. Psychopharmacol. 28 110\u2013113. 10.1097/jcp.0b013e318160862c", "ArticleIdList": ["10.1097/jcp.0b013e318160862c", "18204357"]}, {"Citation": "Baum L., Ng A. (2004). Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer\u2019s disease animal models. J. Alzheimers Dis. 6 367\u2013377. 10.3233/JAD-2004-6403", "ArticleIdList": ["10.3233/JAD-2004-6403", "15345806"]}, {"Citation": "Beason-Held L. L., Goh J. O., An Y., Kraut M. A., O\u2019Brien R. J., Ferrucci L., et al. (2013). Changes in brain function occur years before the onset of cognitive impairment. J. Neurosci. 33 18008\u201318014. 10.1523/JNEUROSCI.1402-13.2013", "ArticleIdList": ["10.1523/JNEUROSCI.1402-13.2013", "PMC3828456", "24227712"]}, {"Citation": "Begley D. J. (2004). ABC transporters and the blood-brain barrier. Curr. Pharm. Des. 10 1295\u20131312. 10.2174/1381612043384844", "ArticleIdList": ["10.2174/1381612043384844", "15134482"]}, {"Citation": "Begum A. N., Jones M. R., Lim G. P., Morihara T., Kim P., Heath D. D., et al. (2008). Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer\u2019s disease. J. Pharmacol. Exp. Ther. 326 196\u2013208. 10.1124/jpet.108.137455", "ArticleIdList": ["10.1124/jpet.108.137455", "PMC2527621", "18417733"]}, {"Citation": "Bhanumathy M., Harish M., Shivaprasad H., Sushma G. (2010). Nootropic activity of Celastrus paniculatus seed. Pharm. Biol. 48 324\u2013327. 10.3109/13880200903127391", "ArticleIdList": ["10.3109/13880200903127391", "20645820"]}, {"Citation": "Bhaskar S., Tian F., Stoeger T., Kreyling W., de la Fuente J. M., Graz\u00fa V., et al. (2010). Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part. Fibre Toxicol. 7:3. 10.1186/1743-8977-7-3", "ArticleIdList": ["10.1186/1743-8977-7-3", "PMC2847536", "20199661"]}, {"Citation": "Bihaqi S. W., Singh A. P., Tiwari M. (2012). Supplementation of Convolvulus pluricaulis attenuates scopolamine-induced increased tau and Amyloid precursor protein (A\u03b2PP) expression in rat brain. Indian J. Pharmacol. 44 593\u2013598. 10.4103/0253-7613.100383", "ArticleIdList": ["10.4103/0253-7613.100383", "PMC3480791", "23112420"]}, {"Citation": "Bird T. D. (2008). Genetic aspects of Alzheimer disease. Genet. Med. 10 231\u2013239. 10.1097/GIM.0b013e31816b64dc", "ArticleIdList": ["10.1097/GIM.0b013e31816b64dc", "PMC2690397", "18414205"]}, {"Citation": "Biswas K., Islam A., Sharmin T., Biswas P. K. (2015). In-vitro cholinesterase inhibitory activity of dry fruit extract of Phyllanthus emblica relevant to the treatment of Alzheimer\u2019s disease. J. Phytopharmacol. 4 5\u20138."}, {"Citation": "Blusztajn J. K., Slack B. E., Mellott T. J. (2017). Neuroprotective actions of dietary choline. Nutrients 9:E815. 10.3390/nu9080815", "ArticleIdList": ["10.3390/nu9080815", "PMC5579609", "28788094"]}, {"Citation": "Bohrmann B., Baumann K., Benz J., Gerber F., Huber W., Knoflach F., et al. (2012). Gantenerumab: a novel human anti-A\u03b2 antibody demonstrates sustained cerebral amyloid-\u03b2 binding and elicits cell-mediated removal of human amyloid-\u03b2. J. Alzheimers Dis. 28 49\u201369. 10.3233/JAD-2011-110977", "ArticleIdList": ["10.3233/JAD-2011-110977", "21955818"]}, {"Citation": "Canovi M., Markoutsa E., Lazar A. N., Pampalakis G., Clemente C., Re F., et al. (2011). The binding affinity of anti-A\u03b21-42 MAb-decorated nanoliposomes to A\u03b21-42 peptides in vitro and to amyloid deposits in post-mortem tissue. Biomaterials 32 5489\u20135497. 10.1016/j.biomaterials.2011.04.020", "ArticleIdList": ["10.1016/j.biomaterials.2011.04.020", "21529932"]}, {"Citation": "Carradori D., Balducci C., Re F., Brambilla D., Le Droumaguet B., Flores O., et al. (2018). Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer\u2019s disease-like transgenic mouse model. Nanomedicine 14 609\u2013618. 10.1016/j.nano.2017.12.006", "ArticleIdList": ["10.1016/j.nano.2017.12.006", "29248676"]}, {"Citation": "Casey D. A., Antimisiaris D., O\u2019Brien J. (2010). Drugs for Alzheimer\u2019s disease: are they effective? Pharm. Ther. 35 208\u2013211.", "ArticleIdList": ["PMC2873716", "20498822"]}, {"Citation": "Chaudhari K. S., Tiwari N. R., Tiwari R. R., Sharma R. S. (2017). Neurocognitive effect of nootropic drug brahmi (Bacopa monnieri) in Alzheimer\u2019s disease. Ann. Neurosci. 24 111\u2013122. 10.1159/000475900", "ArticleIdList": ["10.1159/000475900", "PMC5448442", "28588366"]}, {"Citation": "Chaudhary B., Bist R. (2017). Protective manifestation of bacoside A and bromelain in terms of cholinesterases, gamma-amino butyric acid, serotonin level and stress proteins in the brain of dichlorvos-intoxicated mice. Cell Stress Chaperones 22 371\u2013376. 10.1007/s12192-017-0773-1", "ArticleIdList": ["10.1007/s12192-017-0773-1", "PMC5425367", "28321764"]}, {"Citation": "Chen W., Guo Y., Yang W., Zheng P., Zeng J., Tong W. (2015). Protective effect of ginsenoside Rb1 on integrity of blood\u2013brain barrier following cerebral ischemia. Exp. Brain Res. 233 2823\u20132831. 10.1007/s00221-015-4352-3", "ArticleIdList": ["10.1007/s00221-015-4352-3", "26070903"]}, {"Citation": "Chen Z., Mao X., Liu A., Gao X., Chen X., Ye M., et al. (2015). Osthole, a natural coumarin improves cognitive impairments and BBB dysfunction after transient global brain ischemia in C57 BL/6J mice: involvement of Nrf2 pathway. Neurochem. Res. 40 186\u2013194. 10.1007/s11064-014-1483-z", "ArticleIdList": ["10.1007/s11064-014-1483-z", "25424966"]}, {"Citation": "Chen X., Hua H.-P., Liang L., Liu L.-J. (2017). The oral pretreatment of glycyrrhizin prevents surgery-induced cognitive impairment in aged mice by reducing neuroinflammation and Alzheimer\u2019s-related pathology via HMGB1 inhibition. J. Mol. Neurosci. 63 385\u2013395. 10.1007/s12031-017-0989-7", "ArticleIdList": ["10.1007/s12031-017-0989-7", "29034441"]}, {"Citation": "Cheng K. K., Chan P. S., Fan S., Kwan S. M., Yeung K. L., Wang Y.-X. J., et al. (2015). Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer\u2019s disease mice using magnetic resonance imaging (MRI). Biomaterials 44 155\u2013172. 10.1016/j.biomaterials.2014.12.005", "ArticleIdList": ["10.1016/j.biomaterials.2014.12.005", "25617135"]}, {"Citation": "Cheng K. K., Yeung C. F., Ho S. W., Chow S. F., Chow A. H., Baum L. (2013). Highly stabilized curcumin nanoparticles tested in an in vitro blood\u2013brain barrier model and in Alzheimer\u2019s disease Tg2576 mice. AAPS J. 15 324\u2013336. 10.1208/s12248-012-9444-4", "ArticleIdList": ["10.1208/s12248-012-9444-4", "PMC3675736", "23229335"]}, {"Citation": "Chu Y.-F., Brown P. H., Lyle B. J., Chen Y., Black R. M., Williams C. E., et al. (2009). Roasted coffees high in lipophilic antioxidants and chlorogenic acid lactones are more neuroprotective than green coffees. J. Agric. Food Chem. 57 9801\u20139808. 10.1021/jf902095z", "ArticleIdList": ["10.1021/jf902095z", "19772322"]}, {"Citation": "Col\u00edn-Gonz\u00e1lez A. L., Santana R. A., Silva-Islas C. A., Ch\u00e1nez-C\u00e1rdenas M. E., Santamar\u00eda A., Maldonado P. D. (2012). The antioxidant mechanisms underlying the aged garlic extract-and S-allylcysteine-induced protection. Oxid. Med. Cell. Longev. 2012:907162. 10.1155/2012/907162", "ArticleIdList": ["10.1155/2012/907162", "PMC3363007", "22685624"]}, {"Citation": "Cropley V., Croft R., Silber B., Neale C., Scholey A., Stough C., et al. (2012). Does coffee enriched with chlorogenic acids improve mood and cognition after acute administration in healthy elderly? A pilot study. Psychopharmacology 219 737\u2013749. 10.1007/s00213-011-2395-0", "ArticleIdList": ["10.1007/s00213-011-2395-0", "21773723"]}, {"Citation": "Cui Z., Lockman P. R., Atwood C. S., Hsu C.-H., Gupte A., Allen D. D., et al. (2005). Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer\u2019s and other CNS diseases. Eur. J. Pharm. Biopharm. 59 263\u2013272. 10.1016/j.ejpb.2004.07.009", "ArticleIdList": ["10.1016/j.ejpb.2004.07.009", "15661498"]}, {"Citation": "Cummings J., Morstorf T., Lee G. (2016). Alzheimer\u2019s drug-development pipeline: 2016. Alzheimers Dement. (N.Y.) 2 222-232. 10.1016/j.trci.2016.07.001", "ArticleIdList": ["10.1016/j.trci.2016.07.001", "PMC5651348", "29067309"]}, {"Citation": "Daneman R., Prat A. (2015). The blood\u2013brain barrier. Cold Spring Harb. Perspect. Biol. 7:a020412. 10.1101/cshperspect.a020412", "ArticleIdList": ["10.1101/cshperspect.a020412", "PMC4292164", "25561720"]}, {"Citation": "Danhier F., Ansorena E., Silva J. M., Coco R., Le Breton A., Pr\u00e9at V. (2012). PLGA-based nanoparticles: an overview of biomedical applications. J. Control. Release 161 505\u2013522. 10.1016/j.jconrel.2012.01.043", "ArticleIdList": ["10.1016/j.jconrel.2012.01.043", "22353619"]}, {"Citation": "De Campos A. M., S\u00e1nchez A., Alonso M. J. (2001). Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int. J. Pharm. 224 159\u2013168. 10.1016/S0378-5173(01)00760-8", "ArticleIdList": ["10.1016/S0378-5173(01)00760-8", "11472825"]}, {"Citation": "DeFeudis F. V. (2002). Effects of Ginkgo biloba extract (EGb 761) on gene expression: possible relevance to neurological disorders and age-associated cognitive impairment. Drug Dev. Res. 57 214\u2013235. 10.1002/ddr.10151", "ArticleIdList": ["10.1002/ddr.10151"]}, {"Citation": "Dhanasekaran M., Holcomb L. A., Hitt A. R., Tharakan B., Porter J. W., Young K. A., et al. (2009). Centella asiatica extract selectively decreases amyloid \u03b2 levels in hippocampus of Alzheimer\u2019s disease animal model. Phytother. Res. 23 14\u201319. 10.1002/ptr.2405", "ArticleIdList": ["10.1002/ptr.2405", "19048607"]}, {"Citation": "Di Stefano A., Iannitelli A., Laserra S., Sozio P. (2011). Drug delivery strategies for Alzheimer\u2019s disease treatment. Expert Opin. Drug Deliv. 8 581\u2013603. 10.1517/17425247.2011.561311", "ArticleIdList": ["10.1517/17425247.2011.561311", "21391862"]}, {"Citation": "Dubey G., Pathak S., Gupta B. (1994). Combined effect of Brahmi (Bacopa monniera) and Shankhpushpi (Convolvulus pluricaulis) on cognitive functions. Pharmacopsychoecol 7 249\u2013251."}, {"Citation": "Dutta P. K., Dutta J., Tripathi V. (2004). Chitin and chitosan: chemistry, properties and applications. J. Sci. Ind. Res. 63 20\u201331."}, {"Citation": "Emmanuel R., Saravanan M., Ovais M., Padmavathy S., Shinwari Z. K., Prakash P. (2017). Antimicrobial efficacy of drug blended biosynthesized colloidal gold nanoparticles from Justicia glauca against oral pathogens: a nanoantibiotic approach. Microb. Pathog. 113 295\u2013302. 10.1016/j.micpath.2017.10.055", "ArticleIdList": ["10.1016/j.micpath.2017.10.055", "29101061"]}, {"Citation": "Erickson M. A., Banks W. A. (2013). Blood\u2013brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease. J. Cereb. Blood Flow Metab. 33 1500\u20131513. 10.1038/jcbfm.2013.135", "ArticleIdList": ["10.1038/jcbfm.2013.135", "PMC3790938", "23921899"]}, {"Citation": "Esquivel P., Jim\u00e9nez V. M. (2012). Functional properties of coffee and coffee by-products. Food Res. Int. 46 488\u2013495. 10.1016/j.foodres.2011.05.028", "ArticleIdList": ["10.1016/j.foodres.2011.05.028"]}, {"Citation": "Fang L., Gou S., Liu X., Cao F., Cheng L. (2014). Design, synthesis and anti-Alzheimer properties of dimethylaminomethyl-substituted curcumin derivatives. Bioorg. Med. Chem. Lett. 24 40\u201343. 10.1016/j.bmcl.2013.12.011", "ArticleIdList": ["10.1016/j.bmcl.2013.12.011", "24342238"]}, {"Citation": "Fang W., Deng Y., Li Y., Shang E., Fang F., Lv P., et al. (2010). Blood brain barrier permeability and therapeutic time window of Ginkgolide B in ischemia\u2013reperfusion injury. Eur. J. Pharm. Sci. 39 8\u201314. 10.1016/j.ejps.2009.10.002", "ArticleIdList": ["10.1016/j.ejps.2009.10.002", "19833202"]}, {"Citation": "Faria A., Meireles M., Fernandes I., Santos-Buelga C., Gonzalez-Manzano S., Due\u00f1as M., et al. (2014). Flavonoid metabolites transport across a human BBB model. Food Chem. 149 190\u2013196. 10.1016/j.foodchem.2013.10.095", "ArticleIdList": ["10.1016/j.foodchem.2013.10.095", "24295694"]}, {"Citation": "Faria A., Pestana D., Teixeira D., Couraud P.-O., Romero I., Weksler B., et al. (2011). Insights into the putative catechin and epicatechin transport across blood-brain barrier. Food Funct. 2 39\u201344. 10.1039/C0FO00100G", "ArticleIdList": ["10.1039/C0FO00100G", "21773584"]}, {"Citation": "Farlow M. R., Andreasen N., Riviere M.-E., Vostiar I., Vitaliti A., Sovago J., et al. (2015). Long-term treatment with active A\u03b2 immunotherapy with CAD106 in mild Alzheimer\u2019s disease. Alzheimers Res. Ther. 7:23. 10.1186/s13195-015-0108-3", "ArticleIdList": ["10.1186/s13195-015-0108-3", "PMC4410460", "25918556"]}, {"Citation": "Farokhnia M., Shafiee Sabet M., Iranpour N., Gougol A., Yekehtaz H., Alimardani R., et al. (2014). Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer\u2019s disease: a double-blind randomized clinical trial. Hum. Psychopharmacol. 29 351\u2013359. 10.1002/hup.2412", "ArticleIdList": ["10.1002/hup.2412", "25163440"]}, {"Citation": "Fazil M., Md S., Haque S., Kumar M., Baboota S., Sahni J. K., et al. (2012). Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur. J. Pharm. Sci. 47 6\u201315. 10.1016/j.ejps.2012.04.013", "ArticleIdList": ["10.1016/j.ejps.2012.04.013", "22561106"]}, {"Citation": "Finley J. W., Gao S. (2017). A perspective on Crocus sativus L.(Saffron) constituent crocin: a potent water-soluble antioxidant and potential therapy for Alzheimer\u2019s disease. J. Agric. Food Chem. 65 1005\u20131020. 10.1021/acs.jafc.6b04398", "ArticleIdList": ["10.1021/acs.jafc.6b04398", "28098452"]}, {"Citation": "Fonseca-Santos B., Gremi\u00e3o M. P. D., Chorilli M. (2015). Nanotechnology-based drug delivery systems for the treatment of Alzheimer\u2019s disease. Int. J. Nanomedicine 10 4981\u20135003. 10.2147/IJN.S87148", "ArticleIdList": ["10.2147/IJN.S87148", "PMC4531021", "26345528"]}, {"Citation": "Fran\u00e7a M. B., Lima K. C., Eleutherio E. C. (2017). Oxidative stress and amyloid toxicity: insights from yeast. J. Cell. Biochem. 118 1442\u20131452. 10.1002/jcb.25803", "ArticleIdList": ["10.1002/jcb.25803", "27883213"]}, {"Citation": "Galimberti D., Scarpini E. (2010). Treatment of Alzheimer\u2019s disease: symptomatic and disease-modifying approaches. Curr. Aging Sci. 3 46\u201356. 10.2174/1874609811003010046", "ArticleIdList": ["10.2174/1874609811003010046", "20298170"]}, {"Citation": "Garrido-Maraver J., Cordero M. D., Oropesa-\u00c1vila M., Vega A. F., De La Mata M., Pav\u00f3n A. D., et al. (2014). Coenzyme q10 therapy. Mol. Syndromol. 5 187\u2013197. 10.1159/000360101", "ArticleIdList": ["10.1159/000360101", "PMC4112525", "25126052"]}, {"Citation": "Geiser R. J., Chastain S. E., Moss M. A. (2017). Regulation of Bace1 Mrna expression in Alzheimer\u2019S disease by green tea catechins and black tea theaflavins. Biophys. J. 112:362a 10.1016/j.bpj.2016.11.1965", "ArticleIdList": ["10.1016/j.bpj.2016.11.1965"]}, {"Citation": "Gharibi A., Khalili M., Kiasalari Z., Hoseinirad M. (2013). The effect of Zingiber officinalis L. on learning and memory in rats. J. Bas. Clin. Pathophysiol. 2 2013\u20132014."}, {"Citation": "Ghosh A., Sarkar S., Mandal A. K., Das N. (2013). Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats. PLoS One 8:e57735. 10.1371/journal.pone.0057735", "ArticleIdList": ["10.1371/journal.pone.0057735", "PMC3631169", "23620721"]}, {"Citation": "Giacobini E. (2004). Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol. Res. 50 433\u2013440. 10.1016/j.phrs.2003.11.017", "ArticleIdList": ["10.1016/j.phrs.2003.11.017", "15304240"]}, {"Citation": "Giljohann D. A., Mirkin C. A. (2009). Drivers of biodiagnostic development. Nature 462 461\u2013464. 10.1038/nature08605", "ArticleIdList": ["10.1038/nature08605", "PMC3936986", "19940916"]}, {"Citation": "Gobbi M., Re F., Canovi M., Beeg M., Gregori M., Sesana S., et al. (2010). Lipid-based nanoparticles with high binding affinity for amyloid-\u03b21\u201342 peptide. Biomaterials 31 6519\u20136529. 10.1016/j.biomaterials.2010.04.044", "ArticleIdList": ["10.1016/j.biomaterials.2010.04.044", "20553982"]}, {"Citation": "Godkar P., Gordon R., Ravindran A., Doctor B. (2006). Celastrus paniculatus seed oil and organic extracts attenuate hydrogen peroxide-and glutamate-induced injury in embryonic rat forebrain neuronal cells. Phytomedicine 13 29\u201336. 10.1016/j.phymed.2003.11.011", "ArticleIdList": ["10.1016/j.phymed.2003.11.011", "16360930"]}, {"Citation": "Grzybowska B., S\u0142oczy\u00f1ski J., Grabowski R., Wcis\u0142o K., Koz\u0142owska A., Stoch J., et al. (1998). Chromium oxide/alumina catalysts in oxidative dehydrogenation of isobutane. J. Catal. 178 687\u2013700. 10.1006/jcat.1998.2203", "ArticleIdList": ["10.1006/jcat.1998.2203"]}, {"Citation": "Hebert L. E., Weuve J., Scherr P. A., Evans D. A. (2013). Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census. Neurology 80 1778\u20131783. 10.1212/WNL.0b013e31828726f5", "ArticleIdList": ["10.1212/WNL.0b013e31828726f5", "PMC3719424", "23390181"]}, {"Citation": "Heneka M. T., Carson M. J., El Khoury J., Landreth G. E., Brosseron F., Feinstein D. L., et al. (2015). Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14 388\u2013405. 10.1016/S1474-4422(15)70016-5", "ArticleIdList": ["10.1016/S1474-4422(15)70016-5", "PMC5909703", "25792098"]}, {"Citation": "Ho Y.-S., Hung C. H.-L., Chang R. C.-C. (2013). Green tea and neurodegeneration in Alzheimer\u2019s disease, in Tea in Health and Disease Prevention, ed. Preedy V. R. (New York, NY: Elsevier; ), 691\u2013704."}, {"Citation": "Hoi C. P., Ho Y. P., Baum L., Chow A. H. (2010). Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells. Phytother. Res. 24 1538\u20131542. 10.1002/ptr.3178", "ArticleIdList": ["10.1002/ptr.3178", "20878707"]}, {"Citation": "Hu Z., Bian X., Liu X., Zhu Y., Zhang X., Chen S., et al. (2013). Honokiol protects brain against ischemia\u2013reperfusion injury in rats through disrupting PSD95\u2013nNOS interaction. Brain Res. 1491 204\u2013212. 10.1016/j.brainres.2012.11.004", "ArticleIdList": ["10.1016/j.brainres.2012.11.004", "23148950"]}, {"Citation": "Huang M., Xie S.-S., Jiang N., Lan J.-S., Kong L.-Y., Wang X.-B. (2015). Multifunctional coumarin derivatives: monoamine oxidase B (MAO-B) inhibition, anti-\u03b2-amyloid (A\u03b2) aggregation and metal chelation properties against Alzheimer\u2019s disease. Bioorg. Med. Chem. Lett. 25 508\u2013513. 10.1016/j.bmcl.2014.12.034", "ArticleIdList": ["10.1016/j.bmcl.2014.12.034", "25542589"]}, {"Citation": "Ishisaka A., Ichikawa S., Sakakibara H., Piskula M. K., Nakamura T., Kato Y., et al. (2011). Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radic. Biol. Med. 51 1329\u20131336. 10.1016/j.freeradbiomed.2011.06.017", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.06.017", "21741473"]}, {"Citation": "Ismail M. F., ElMeshad A. N., Salem N. A.-H. (2013). Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer\u2019s disease. Int. J. Nanomedicine 8 393\u2013406. 10.2147/IJN.S39232", "ArticleIdList": ["10.2147/IJN.S39232", "PMC3558309", "23378761"]}, {"Citation": "Ito H., Sun X.-L., Watanabe M., Okamoto M., Hatano T. (2008). Chlorogenic acid and its metabolite m-coumaric acid evoke neurite outgrowth in hippocampal neuronal cells. Biosci. Biotechnol. Biochem. 72 885\u2013888. 10.1271/bbb.70670", "ArticleIdList": ["10.1271/bbb.70670", "18323641"]}, {"Citation": "Jalali S., Zarrinhaghighi A., Sadraei S., Ghasemi Y., Sakhteman A., Faridi P. (2018). A system pharmacology study for deciphering anti depression activity of Nardostachys jatamansi. Curr. Drug Metab. 19 469\u2013476. 10.2174/1389200219666180305151011", "ArticleIdList": ["10.2174/1389200219666180305151011", "29512454"]}, {"Citation": "Jameel E., Umar T., Kumar J., Hoda N. (2016). Coumarin: a privileged scaffold for the design and development of antineurodegenerative agents. Chem. Biol. Drug Des. 87 21\u201338. 10.1111/cbdd.12629", "ArticleIdList": ["10.1111/cbdd.12629", "26242562"]}, {"Citation": "James S. A., Churches Q. I., de Jonge M. D., Birchall I. E., Streltsov V., McColl G., et al. (2016). Iron, copper, and zinc concentration in A\u03b2 plaques in the APP/PS1 mouse model of Alzheimer\u2019s disease correlates with metal levels in the surrounding neuropil. ACS Chem. Neurosci. 8 629\u2013637. 10.1021/acschemneuro.6b00362", "ArticleIdList": ["10.1021/acschemneuro.6b00362", "27958708"]}, {"Citation": "Jayaprakasam B., Padmanabhan K., Nair M. G. (2010). Withanamides in Withania somnifera fruit protect PC-12 cells from \u03b2-amyloid responsible for Alzheimer\u2019s disease. Phytother. Res. 24 859\u2013863.", "ArticleIdList": ["19957250"]}, {"Citation": "Jiang J., Wang W., Sun Y. J., Hu M., Li F., Zhu D. Y. (2007). Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood\u2013brain barrier damage. Eur. J. Pharmacol. 561 54\u201362. 10.1016/j.ejphar.2006.12.028", "ArticleIdList": ["10.1016/j.ejphar.2006.12.028", "17303117"]}, {"Citation": "Johansson B. B. (1990). The physiology of the blood-brain barrier, in Circulating Regulatory Factors and Neuroendocrine Function, eds Porter J. C., Je\u017eov\u00e1 D. (Boston, MA: Springer; ), 25\u201339. 10.1007/978-1-4684-5799-5_2", "ArticleIdList": ["10.1007/978-1-4684-5799-5_2"]}, {"Citation": "Jose S., Sowmya S., Cinu T., Aleykutty N., Thomas S., Souto E. (2014). Surface modified PLGA nanoparticles for brain targeting of Bacoside-A. Eur. J. Pharm. Sci. 63 29\u201335. 10.1016/j.ejps.2014.06.024", "ArticleIdList": ["10.1016/j.ejps.2014.06.024", "25010261"]}, {"Citation": "Joubert J., Foka G. B., Repsold B. P., Oliver D. W., Kapp E., Malan S. F. (2017). Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer\u2019s disease. Eur. J. Med. Chem. 125 853\u2013864. 10.1016/j.ejmech.2016.09.041", "ArticleIdList": ["10.1016/j.ejmech.2016.09.041", "27744252"]}, {"Citation": "Karami M., Bathaie S. Z., Tiraihi T., Habibi-Rezaei M., Arabkheradmand J., Faghihzadeh S. (2013). Crocin improved locomotor function and mechanical behavior in the rat model of contused spinal cord injury through decreasing calcitonin gene related peptide (CGRP). Phytomedicine 21 62\u201367. 10.1016/j.phymed.2013.07.013", "ArticleIdList": ["10.1016/j.phymed.2013.07.013", "24051216"]}, {"Citation": "Karkada G., Shenoy K., Halahalli H., Karanth K. (2012). Nardostachys jatamansi extract prevents chronic restraint stress-induced learning and memory deficits in a radial arm maze task. J. Nat. Sci. Biol. Med. 3 125\u2013132. 10.4103/0976-9668.101879", "ArticleIdList": ["10.4103/0976-9668.101879", "PMC3510905", "23225973"]}, {"Citation": "Kaur N., Dhiman M., Perez-Polo J. R., Mantha A. K. (2015). Ginkgolide B revamps neuroprotective role of apurinic/apyrimidinic endonuclease 1 and mitochondrial oxidative phosphorylation against A\u03b225\u201335-induced neurotoxicity in human neuroblastoma cells. J. Neurosci. Res. 93 938\u2013947. 10.1002/jnr.23565", "ArticleIdList": ["10.1002/jnr.23565", "25677400"]}, {"Citation": "Kennedy M. E., Stamford A. W., Chen X., Cox K., Cumming J. N., Dockendorf M. F., et al. (2016). The BACE1 inhibitor verubecestat (MK-8931) reduces CNS \u03b2-amyloid in animal models and in Alzheimer\u2019s disease patients. Sci. Transl. Med. 8:363ra150. 10.1126/scitranslmed.aad9704", "ArticleIdList": ["10.1126/scitranslmed.aad9704", "27807285"]}, {"Citation": "Khachaturian Z. S. (1985). Diagnosis of Alzheimer\u2019s disease. Arch. Neurol. 42 1097\u20131105. 10.1001/archneur.1985.04060100083029", "ArticleIdList": ["10.1001/archneur.1985.04060100083029", "2864910"]}, {"Citation": "Khalil A. T., Ovais M., Ullah I., Ali M., Jan S. A., Shinwari Z. K., et al. (2017a). Bioinspired synthesis of pure massicot phase lead oxide nanoparticles and assessment of their biocompatibility, cytotoxicity and in-vitro biological properties. Arab. J. Chem. (in press). 10.1016/j.arabjc.2017.08.009", "ArticleIdList": ["10.1016/j.arabjc.2017.08.009"]}, {"Citation": "Khalil A. T., Ovais M., Ullah I., Ali M., Shinwari Z. K., Khamlich S., et al. (2017b). Sageretia thea (Osbeck.) mediated synthesis of zinc oxide nanoparticles and its biological applications. Nanomedicine 12 1767\u20131789. 10.2217/nnm-2017-0124", "ArticleIdList": ["10.2217/nnm-2017-0124", "28699838"]}, {"Citation": "Khalil A. T., Ovais M., Ullah I., Ali M., Shinwari Z. K., Hassan D., et al. (2018). Sageretia thea (Osbeck.) modulated biosynthesis of NiO nanoparticles and their in vitro pharmacognostic, antioxidant and cytotoxic potential. Artif. Cells Nanomed. Biotechnol. 46 838\u2013852. 10.1080/21691401.2017.1345928", "ArticleIdList": ["10.1080/21691401.2017.1345928", "28687045"]}, {"Citation": "Khojah H., Edrada-Ebel R. (2017). Identification of bioactive metabolites from Ficus carica and their neuroprotective effects of Alzheimer\u2019s disease. Int. J. Med. Health Sci. 11 2277\u20134505."}, {"Citation": "Kim J., Basak J. M., Holtzman D. M. (2009). The role of apolipoprotein E in Alzheimer\u2019s disease. Neuron 63 287\u2013303. 10.1016/j.neuron.2009.06.026", "ArticleIdList": ["10.1016/j.neuron.2009.06.026", "PMC3044446", "19679070"]}, {"Citation": "Kodera Y., Suzuki A., Imada O., Kasuga S., Sumioka I., Kanezawa A., et al. (2002). Physical, chemical, and biological properties of S-allylcysteine, an amino acid derived from garlic. J. Agric. Food Chem. 50 622\u2013632. 10.1021/jf0106648", "ArticleIdList": ["10.1021/jf0106648", "11804540"]}, {"Citation": "Krishnamurthy R. G., Senut M. C., Zemke D., Min J., Frenkel M. B., Greenberg E. J., et al. (2009). Asiatic acid, a pentacyclic triterpene from Centella asiatica, is neuroprotective in a mouse model of focal cerebral ischemia. J. Neurosci. Res. 87 2541\u20132550. 10.1002/jnr.22071", "ArticleIdList": ["10.1002/jnr.22071", "PMC2941770", "19382233"]}, {"Citation": "Kulkarni P. D., Ghaisas M. M., Chivate N. D., Sankpal P. S. (2011). Memory enhancing activity of Cissampelos pareira in mice. Int. J. Pharm. Pharma. Sci. 3 206\u2013211."}, {"Citation": "Kwon S.-H., Lee H.-K., Kim J.-A., Hong S.-I., Kim H.-C., Jo T.-H., et al. (2010). Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. Eur. J. Pharmacol. 649 210\u2013217. 10.1016/j.ejphar.2010.09.001", "ArticleIdList": ["10.1016/j.ejphar.2010.09.001", "20854806"]}, {"Citation": "Lang D., Ude C., Wurglics M., Schubert-Zsilavecz M., Klein J. (2010). Brain permeability of bilobalide as probed by microdialysis before and after middle cerebral artery occlusion in mice. J. Pharm. Pharm. Sci. 13 607\u2013614. 10.18433/J31C7Q", "ArticleIdList": ["10.18433/J31C7Q", "21486534"]}, {"Citation": "Laribi B., Kouki K., M\u2019Hamdi M., Bettaieb T. (2015). Coriander (Coriandrum sativum L.) and its bioactive constituents. Fitoterapia 103 9\u201326. 10.1016/j.fitote.2015.03.012", "ArticleIdList": ["10.1016/j.fitote.2015.03.012", "25776008"]}, {"Citation": "Lee Y. K., Yuk D. Y., Kim T. I., Kim Y. H., Kim K. T., Kim K. H., et al. (2009). Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity. J. Nat. Med. 63 274\u2013282. 10.1007/s11418-009-0330-z", "ArticleIdList": ["10.1007/s11418-009-0330-z", "PMC2690856", "19343477"]}, {"Citation": "Li J., Yue M., Zhou D., Wang M., Zhang H. (2017). Abcb1a but not Abcg2 played a predominant role in limiting the brain distribution of Huperzine A in mice. Food Chem. Toxicol. 107 68\u201373. 10.1016/j.fct.2017.06.005", "ArticleIdList": ["10.1016/j.fct.2017.06.005", "28587984"]}, {"Citation": "Li J., Zhou L., Ye D., Huang S., Shao K., Huang R., et al. (2011). Choline-derivate-modified nanoparticles for brain-targeting gene delivery. Adv. Mater. 23 4516\u20134520. 10.1002/adma.201101899", "ArticleIdList": ["10.1002/adma.201101899", "21898606"]}, {"Citation": "Li P., Matsunaga K., Yamakuni T., Ohizumi Y. (2003). Nardosinone, the first enhancer of neurite outgrowth-promoting activity of staurosporine and dibutyryl cyclic AMP in PC12D cells. Dev. Brain Res. 145 177\u2013183. 10.1016/S0165-3806(03)00239-6", "ArticleIdList": ["10.1016/S0165-3806(03)00239-6", "14604758"]}, {"Citation": "Liang X.-F., Wang H.-J., Tian H., Luo H., Chang J. (2008). Syntheis, structure and properties of novel quaternized carboxymethyl chitosan with drug loading capacity. Acta Phys. Chim. Sin. 24 223\u2013229. 10.1016/S1872-1508(08)60011-X", "ArticleIdList": ["10.1016/S1872-1508(08)60011-X"]}, {"Citation": "Lim G. P., Chu T., Yang F., Beech W., Frautschy S. A., Cole G. M. (2001). The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21 8370\u20138377. 10.1523/JNEUROSCI.21-21-08370.2001", "ArticleIdList": ["10.1523/JNEUROSCI.21-21-08370.2001", "PMC6762797", "11606625"]}, {"Citation": "Liu G., Men P., Kudo W., Perry G., Smith M. A. (2009). Nanoparticle\u2013chelator conjugates as inhibitors of amyloid-\u03b2 aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease. Neurosci. Lett. 455 187\u2013190. 10.1016/j.neulet.2009.03.064", "ArticleIdList": ["10.1016/j.neulet.2009.03.064", "PMC2683427", "19429118"]}, {"Citation": "Liu Q. F., Jeong H., Lee J. H., Hong Y. K., Oh Y., Kim Y.-M., et al. (2016). Coriandrum sativum suppresses A\u03b242-induced ROS increases, glial cell proliferation, and ERK activation. Am. J. Chin. Med. 44 1325\u20131347. 10.1142/S0192415X16500749", "ArticleIdList": ["10.1142/S0192415X16500749", "27776428"]}, {"Citation": "Lockman P., Mumper R., Khan M., Allen D. (2002). Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev. Ind. Pharm. 28 1\u201313. 10.1081/DDC-120001481", "ArticleIdList": ["10.1081/DDC-120001481", "11858519"]}, {"Citation": "Loveman E., Green C., Kirby J., Takeda A., Picot J., Payne E., et al. (2006). The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer\u2019s disease. Health Technol. Assess. 10 iii\u2013iv, ix\u2013xi, 1\u2013160.", "ArticleIdList": ["16409879"]}, {"Citation": "Ma T., Gong K., Yan Y., Zhang L., Tang P., Zhang X., et al. (2013). Huperzine A promotes hippocampal neurogenesis in vitro and in vivo. Brain Res. 1506 35\u201343. 10.1016/j.brainres.2013.02.026", "ArticleIdList": ["10.1016/j.brainres.2013.02.026", "23454433"]}, {"Citation": "Maclennan K. M., Darlington C. L., Smith P. F. (2002). The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog. Neurobiol. 67 235\u2013257. 10.1016/S0301-0082(02)00015-1", "ArticleIdList": ["10.1016/S0301-0082(02)00015-1", "12169298"]}, {"Citation": "Madgula V. L., Avula B., Yu Y.-B., Wang Y.-H., Tchantchou F., Fisher S., et al. (2010). Intestinal and blood-brain barrier permeability of ginkgolides and bilobalide: in vitro and in vivo approaches. Planta Med. 76 599\u2013606. 10.1055/s-0029-1240601", "ArticleIdList": ["10.1055/s-0029-1240601", "19937548"]}, {"Citation": "Mahrous R., Ghareeb D. A., Fathy H. M., EL-Khair R. M. A., Omar A. A. (2017). The protective effect of Egyptian Withania somnifera against Alzheimer\u2019s. Med. Aromat Plants 6:285 10.4172/2167-0412.1000285", "ArticleIdList": ["10.4172/2167-0412.1000285"]}, {"Citation": "Malik J., Karan M., Dogra R. (2017). Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism. Pharm. Biol. 55 980\u2013990. 10.1080/13880209.2017.1285945", "ArticleIdList": ["10.1080/13880209.2017.1285945", "PMC6130694", "28164735"]}, {"Citation": "Mandal S., Debnath K., Jana N. R., Jana N. R. (2017). Trehalose-functionalized gold nanoparticle for inhibiting intracellular protein aggregation. Langmuir 33 13996\u201314003. 10.1021/acs.langmuir.7b02202", "ArticleIdList": ["10.1021/acs.langmuir.7b02202", "29125765"]}, {"Citation": "Mangialasche F., Solomon A., Winblad B., Mecocci P., Kivipelto M. (2010). Alzheimer\u2019s disease: clinical trials and drug development. Lancet Neurol. 9 702\u2013716. 10.1016/S1474-4422(10)70119-8", "ArticleIdList": ["10.1016/S1474-4422(10)70119-8", "20610346"]}, {"Citation": "Mani V., Parle M. (2009). Memory-enhancing activity of Coriandrum sativum in rats. Pharmacologyonline 2 827\u2013839."}, {"Citation": "Mao X., Yin W., Liu M., Ye M., Liu P., Liu J., et al. (2011). Osthole, a natural coumarin, improves neurobehavioral functions and reduces infarct volume and matrix metalloproteinase-9 activity after transient focal cerebral ischemia in rats. Brain Res. 1385 275\u2013280. 10.1016/j.brainres.2011.02.015", "ArticleIdList": ["10.1016/j.brainres.2011.02.015", "21316348"]}, {"Citation": "Markoutsa E., Pampalakis G., Niarakis A., Romero I. A., Weksler B., Couraud P. -O., et al. (2011). Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line. Eur. J. Pharm. Biopharm. 77 265\u2013274. 10.1016/j.ejpb.2010.11.015", "ArticleIdList": ["10.1016/j.ejpb.2010.11.015", "21118722"]}, {"Citation": "Markoutsa E., Papadia K., Clemente C., Flores O., Antimisiaris S. G. (2012). Anti-A\u03b2-MAb and dually decorated nanoliposomes: effect of A\u03b21-42 peptides on interaction with hCMEC/D3 cells. Eur. J. Pharm. Biopharm. 81 49\u201356. 10.1016/j.ejpb.2012.02.006", "ArticleIdList": ["10.1016/j.ejpb.2012.02.006", "22386910"]}, {"Citation": "Markoutsa E., Papadia K., Giannou A., Spella M., Cagnotto A., Salmona M., et al. (2014). Mono and dually decorated nanoliposomes for brain targeting, in vitro and in vivo studies. Pharm. Res. 31 1275\u20131289. 10.1007/s11095-013-1249-3", "ArticleIdList": ["10.1007/s11095-013-1249-3", "24338512"]}, {"Citation": "Marumoto S., Okuno Y., Miyazawa M. (2017). Inhibition of \u03b2-secretase activity by monoterpenes, sesquiterpenes, and C13 norisoprenoids. J. Oleo Sci. 66 851\u2013855. 10.5650/jos.ess16188", "ArticleIdList": ["10.5650/jos.ess16188", "28381772"]}, {"Citation": "Masserini M. (2013). Nanoparticles for brain drug delivery. ISRN Biochem. 2013:238428. 10.1155/2013/238428", "ArticleIdList": ["10.1155/2013/238428", "PMC4392984", "25937958"]}, {"Citation": "Md S., Ali M., Baboota S., Sahni J. K., Bhatnagar A., et al. (2014). Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Drug Dev. Ind. Pharm. 40 278\u2013287. 10.3109/03639045.2012.758130", "ArticleIdList": ["10.3109/03639045.2012.758130", "23369094"]}, {"Citation": "Megill A., Lee T., DiBattista A. M., Song J. M., Spitzer M. H., Rubinshtein M., et al. (2013). A tetra (ethylene glycol) derivative of benzothiazole aniline enhances Ras-mediated spinogenesis. J. Neurosci. 33 9306\u20139318. 10.1523/JNEUROSCI.1615-12.2013", "ArticleIdList": ["10.1523/JNEUROSCI.1615-12.2013", "PMC3865503", "23719799"]}, {"Citation": "Mellott T. J., Huleatt O. M., Shade B. N., Pender S. M., Liu Y. B., Slack B. E., et al. (2017). Perinatal choline supplementation reduces amyloidosis and increases choline acetyltransferase expression in the hippocampus of the APPswePS1dE9 Alzheimer\u2019s disease model mice. PLoS One 12:e0170450. 10.1371/journal.pone.0170450", "ArticleIdList": ["10.1371/journal.pone.0170450", "PMC5245895", "28103298"]}, {"Citation": "Meng Q., Wang A., Hua H., Jiang Y., Wang Y., Mu H., et al. (2018). Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer\u2019s disease. Int. J. Nanomedicine 13:705\u2013718. 10.2147/IJN.S151474", "ArticleIdList": ["10.2147/IJN.S151474", "PMC5798568", "29440896"]}, {"Citation": "Minati L., Edginton T., Grazia Bruzzone M., Giaccone G. (2009). Reviews: current concepts in Alzheimer\u2019s disease: a multidisciplinary review. Am. J. Alzheimers Dis. Other Demen. 24 95\u2013121. 10.1177/1533317508328602", "ArticleIdList": ["10.1177/1533317508328602", "19116299"]}, {"Citation": "Mistry A., Stolnik S., Illum L. (2009). Nanoparticles for direct nose-to-brain delivery of drugs. Int. J. Pharm. 379 146\u2013157. 10.1016/j.ijpharm.2009.06.019", "ArticleIdList": ["10.1016/j.ijpharm.2009.06.019", "19555750"]}, {"Citation": "Modi G., Pillay V., Choonara Y. E. (2010). Advances in the treatment of neurodegenerative disorders employing nanotechnology. Ann. N. Y. Acad. Sci. 1184 154\u2013172. 10.1111/j.1749-6632.2009.05108.x", "ArticleIdList": ["10.1111/j.1749-6632.2009.05108.x", "20146696"]}, {"Citation": "Mutlu N. B., Debbbim Z., Y\u0131lmaz \u015e., E\u015fsiz D., Nacar A. (2011). New perspective for the treatment of Alzheimer diseases: liposomal rivastigmine formulations. Drug Dev. Ind. Pharm. 37 775\u2013789. 10.3109/03639045.2010.541262", "ArticleIdList": ["10.3109/03639045.2010.541262", "21231901"]}, {"Citation": "Nazem A., Mansoori G. A. (2011). Nanotechnology for Alzheimer\u2019s disease detection and treatment. Insciences J. 1 169\u2013193. 10.5640/insc.0104169", "ArticleIdList": ["10.5640/insc.0104169"]}, {"Citation": "Nellore J., Pauline C., Amarnath K. (2013). Bacopa monnieri phytochemicals mediated synthesis of platinum nanoparticles and its neurorescue effect on 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine-induced experimental parkinsonism in zebrafish. J. Neurodegener. Dis. 2013:972391. 10.1155/2013/972391", "ArticleIdList": ["10.1155/2013/972391", "PMC4437347", "26317003"]}, {"Citation": "Nie L., Xia J., Li H., Zhang Z., Yang Y., Huang X., et al. (2017). Ginsenoside Rg1 ameliorates behavioral abnormalities and modulates the hippocampal proteomic change in triple transgenic mice of Alzheimer\u2019s disease. Oxid. Med. Cell. Longev. 2017:6473506. 10.1155/2017/6473506", "ArticleIdList": ["10.1155/2017/6473506", "PMC5674513", "29204248"]}, {"Citation": "Nillert N., Pannangrong W., Welbat J. U., Chaijaroonkhanarak W., Sripanidkulchai K., Sripanidkulchai B. (2017). Neuroprotective effects of aged garlic extract on cognitive dysfunction and neuroinflammation induced by \u03b2-amyloid in rats. Nutrients 9:24. 10.3390/nu9010024", "ArticleIdList": ["10.3390/nu9010024", "PMC5295068", "28054940"]}, {"Citation": "Noetzli M., Eap C. B. (2013). Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer\u2019s disease. Clin. Pharmacokinet. 52 225\u2013241. 10.1007/s40262-013-0038-9", "ArticleIdList": ["10.1007/s40262-013-0038-9", "23408070"]}, {"Citation": "Oboh G., Agunloye O. M., Akinyemi A. J., Ademiluyi A. O., Adefegha S. A. (2013). Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer\u2019s disease and some pro-oxidant induced oxidative stress in rats\u2019 brain-in vitro. Neurochem. Res. 38 413\u2013419. 10.1007/s11064-012-0935-6", "ArticleIdList": ["10.1007/s11064-012-0935-6", "23184188"]}, {"Citation": "Ossola B., K\u00e4\u00e4ri\u00e4inen T. M., M\u00e4nnist\u00f6 P. T. (2009). The multiple faces of quercetin in neuroprotection. Expert Opin. Drug Saf. 8 397\u2013409. 10.1517/14740330903026944", "ArticleIdList": ["10.1517/14740330903026944", "19538101"]}, {"Citation": "Ovais M., Ahmad I., Khalil A. T., Mukherjee S., Javed R., Ayaz M., et al. (2018a). Wound healing applications of biogenic colloidal silver and gold nanoparticles: recent trends and future prospects. Appl. Microbiol. Biotechnol. 102 4305\u20134318. 10.1007/s00253-018-8939-z", "ArticleIdList": ["10.1007/s00253-018-8939-z", "29589095"]}, {"Citation": "Ovais M., Ayaz M., Khalil A. T., Shah S. A., Jan M. S., Raza A., et al. (2018b). HPLC-DAD finger printing, antioxidant, cholinesterase, and \u03b1-glucosidase inhibitory potentials of a novel plant Olax nana. BMC Complement. Altern. Med. 18:1. 10.1186/s12906-017-2057-9", "ArticleIdList": ["10.1186/s12906-017-2057-9", "PMC5751879", "29295712"]}, {"Citation": "Ovais M., Khalil A. T., Islam N. U., Ahmad I., Ayaz M., Saravanan M., et al. (2018c). Role of plant phytochemicals and microbial enzymes in biosynthesis of metallic nanoparticles. Appl. Microbiol. Biotechnol. 10.1007/s00253-018-9146-7 [Epub ahead of print].", "ArticleIdList": ["10.1007/s00253-018-9146-7", "29882162"]}, {"Citation": "Ovais M., Khalil A. T., Raza A., Islam N. U., Ayaz M., Saravanan M., et al. (2018d). Multifunctional theranostic applications of biocompatible green-synthesized colloidal nanoparticles. Appl. Microbiol. Biotechnol. 102 4393\u20134408. 10.1007/s00253-018-8928-2", "ArticleIdList": ["10.1007/s00253-018-8928-2", "29594356"]}, {"Citation": "Ovais M., Khalil A. T., Raza A., Khan M. A., Ahmad I., Islam N. U., et al. (2016). Green synthesis of silver nanoparticles via plant extracts: beginning a new era in cancer theranostics. Nanomedicine 12 3157\u20133177. 10.2217/nnm-2016-0279", "ArticleIdList": ["10.2217/nnm-2016-0279", "27809668"]}, {"Citation": "Ovais M., Nadhman A., Khalil A. T., Raza A., Khuda F., Sohail M. F., et al. (2017a). Biosynthesized colloidal silver and gold nanoparticles as emerging leishmanicidal agents: an insight. Nanomedicine 12 2807\u20132819. 10.2217/nnm-2017-0233", "ArticleIdList": ["10.2217/nnm-2017-0233", "29111869"]}, {"Citation": "Ovais M., Raza A., Naz S., Islam N. U., Khalil A. T., Ali S., et al. (2017b). Current state and prospects of the phytosynthesized colloidal gold nanoparticles and their applications in cancer theranostics. Appl. Microbiol. Biotechnol. 101 3551\u20133565. 10.1007/s00253-017-8250-4", "ArticleIdList": ["10.1007/s00253-017-8250-4", "28382454"]}, {"Citation": "Palle S., Neerati P. (2017). Quercetin nanoparticles attenuates scopolamine induced spatial memory deficits and pathological damages in rats. Bull. Fac. Pharm. Cairo Univ. 55 101\u2013106. 10.1016/j.bfopcu.2016.10.004", "ArticleIdList": ["10.1016/j.bfopcu.2016.10.004"]}, {"Citation": "Papadia K., Giannou A. D., Markoutsa E., Bigot C., Vanhoute G., Mourtas S., et al. (2017). Multifunctional LUV liposomes decorated for BBB and amyloid targeting-B. In vivo brain targeting potential in wild-type and APP/PS1 mice. Eur. J. Pharm. Sci. 102 180\u2013187. 10.1016/j.ejps.2017.03.010", "ArticleIdList": ["10.1016/j.ejps.2017.03.010", "28285172"]}, {"Citation": "Pardeshi C. V., Belgamwar V. S. (2013). Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood\u2013brain barrier: an excellent platform for brain targeting. Expert Opin. Drug Deliv. 10 957\u2013972. 10.1517/17425247.2013.790887", "ArticleIdList": ["10.1517/17425247.2013.790887", "23586809"]}, {"Citation": "P\u00e9rez-Severiano F., Salvatierra-S\u00e1nchez R., Rodr\u0131guez-P\u00e9rez M., Cuevas-Mart\u0131nez E. Y., Guevara J., Lim\u00f3n D., et al. (2004). S-Allylcysteine prevents amyloid-\u03b2 peptide-induced oxidative stress in rat hippocampus and ameliorates learning deficits. Eur. J. Pharmacol. 489 197\u2013202. 10.1016/j.ejphar.2004.03.001", "ArticleIdList": ["10.1016/j.ejphar.2004.03.001", "15087243"]}, {"Citation": "Preedy V. R. (2012). Tea in Health and Disease Prevention. Cambridge, MA: Academic Press."}, {"Citation": "Puerta E., Su\u00e1rez-Santiago J. E., Santos-Magalh\u00e3es N. S., Ramirez M. J., Irache J. M. (2017). Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer\u2019s disease. Int. J. Pharm. 517 50\u201357. 10.1016/j.ijpharm.2016.11.061", "ArticleIdList": ["10.1016/j.ijpharm.2016.11.061", "27915007"]}, {"Citation": "Qi F.-Y., Yang L., Tian Z., Zhao M.-G., Liu S.-B., An J.-Z. (2014). Neuroprotective effects of Asiaticoside. Neural Regen. Res. 9 1275\u20131282. 10.4103/1673-5374.137574", "ArticleIdList": ["10.4103/1673-5374.137574", "PMC4160853", "25221579"]}, {"Citation": "Rafii M., Walsh S., Little J., Behan K., Reynolds B., Ward C., et al. (2011). A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology 76 1389\u20131394. 10.1212/WNL.0b013e318216eb7b", "ArticleIdList": ["10.1212/WNL.0b013e318216eb7b", "PMC3269774", "21502597"]}, {"Citation": "Rebai O., Belkhir M., Sanchez-Gomez M. V., Matute C., Fattouch S., Amri M. (2017). Differential molecular targets for neuroprotective effect of chlorogenic acid and its related compounds against glutamate induced excitotoxicity and oxidative stress in rat cortical neurons. Neurochem. Res. 42 3559\u20133572. 10.1007/s11064-017-2403-9", "ArticleIdList": ["10.1007/s11064-017-2403-9", "28948515"]}, {"Citation": "Remya C., Dileep K., Variayr E., Sadasivan C. (2016). An in silico guided identification of nAChR agonists from Withania somnifera. Front. Life Sci. 9 201\u2013213. 10.1080/21553769.2016.1207569", "ArticleIdList": ["10.1080/21553769.2016.1207569"]}, {"Citation": "Rocha S. (2013). Targeted drug delivery across the blood brain barrier in Alzheimer\u2019s disease. Curr. Pharm. Des. 19 6635\u20136646. 10.2174/13816128113199990613", "ArticleIdList": ["10.2174/13816128113199990613", "23621533"]}, {"Citation": "Rotman M., Welling M. M., Bunschoten A., de Backer M. E., Rip J., Nabuurs R. J., et al. (2015). Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer\u2019s disease. J. Control. Release 203 40\u201350. 10.1016/j.jconrel.2015.02.012", "ArticleIdList": ["10.1016/j.jconrel.2015.02.012", "25668771"]}, {"Citation": "Rubio J., Qiong W., Liu X., Jiang Z., Dang H., Chen S.-L., et al. (2011). Aqueous extract of black maca (Lepidium meyenii) on memory impairment induced by ovariectomy in mice. Evid. Based Complement. Alternat. Med. 2011:253958. 10.1093/ecam/nen063", "ArticleIdList": ["10.1093/ecam/nen063", "PMC3096456", "18955369"]}, {"Citation": "Rui W., Yan-Nan L., Guang-Ji W., Hai-Ping H., Xiao-Lan W., Fang Z. (2009). Neuroprotective effects and brain transport of ginsenoside Rg1. Chin. J. Nat. Med. 7 315\u2013320. 10.3724/SP.J.1009.2008.00315", "ArticleIdList": ["10.3724/SP.J.1009.2008.00315"]}, {"Citation": "Sadiq A., Zeb A., Ullah F., Ahmad S., Ayaz M., Rashid U., et al. (2018). Chemical characterization, analgesic, antioxidant, and anticholinesterase potentials of essential oils from Isodon rugosus Wall. ex. Benth. Front. Pharmacol. 9:623. 10.3389/fphar.2018.00623", "ArticleIdList": ["10.3389/fphar.2018.00623", "PMC6008688", "29950997"]}, {"Citation": "Saharia K., Kumar R., Gupta K., Mishra S., Subramaniam J. R. (2016). A novel way of amelioration of amyloid beta induced toxicity in Caenorhabditis elegans. Ann. Neurosci. 23 149\u2013154. 10.1159/000449180", "ArticleIdList": ["10.1159/000449180", "PMC5043337", "27721583"]}, {"Citation": "Sahni J. K., Doggui S., Ali J., Baboota S., Dao L., Ramassamy C. (2011). Neurotherapeutic applications of nanoparticles in Alzheimer\u2019s disease. J. Control. Release 152 208\u2013231. 10.1016/j.jconrel.2010.11.033", "ArticleIdList": ["10.1016/j.jconrel.2010.11.033", "21134407"]}, {"Citation": "Salloway S., Sperling R., Fox N. C., Blennow K., Klunk W., Raskind M., et al. (2014). Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease. N. Engl. J. Med. 370 322\u2013333. 10.1056/NEJMoa1304839", "ArticleIdList": ["10.1056/NEJMoa1304839", "PMC4159618", "24450891"]}, {"Citation": "Salmaso S., Caliceti P. (2013). Stealth properties to improve therapeutic efficacy of drug nanocarriers. J. Drug Deliv. 2013:374252. 10.1155/2013/374252", "ArticleIdList": ["10.1155/2013/374252", "PMC3606770", "23533769"]}, {"Citation": "Serafini M. M., Catanzaro M., Rosini M., Racchi M., Lanni C. (2017). Curcumin in Alzheimer\u2019s disease: Can we think to new strategies and perspectives for this molecule? Pharmacol. Res. 124 146\u2013155. 10.1016/j.phrs.2017.08.004", "ArticleIdList": ["10.1016/j.phrs.2017.08.004", "28811228"]}, {"Citation": "Selkoe D. J. (2001). Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol. Rev. 81 741\u2013766. 10.1152/physrev.2001.81.2.741", "ArticleIdList": ["10.1152/physrev.2001.81.2.741", "11274343"]}, {"Citation": "Seow S. L. S., Hong S. L., Lee G. S., Malek S. N. A., Sabaratnam V. (2017). 6-shogaol, a neuroactive compound of ginger (jahe gajah) induced neuritogenic activity via NGF responsive pathways in PC-12 cells. BMC Complement. Altern. Med. 17:334. 10.1186/s12906-017-1837-6", "ArticleIdList": ["10.1186/s12906-017-1837-6", "PMC5483314", "28646880"]}, {"Citation": "Sevigny J., Chiao P., Bussi\u00e8re T., Weinreb P. H., Williams L., Maier M., et al. (2016). The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537 50\u201356. 10.1038/nature19323", "ArticleIdList": ["10.1038/nature19323", "27582220"]}, {"Citation": "Sharma H. S., Drieu K., Alm P., Westman J. (2000). Role of nitric oxide in blood-brain barrier permeability, brain edema and cell damage following hyperthermic brain injury. An experimental study using EGB-761 and Gingkolide B pretreatment in the rat, in Brain Edema XI. Acta Neurochirurgica Supplements, ed. Mendelow A. D. (Vienna: Springer; ),81\u201386.", "ArticleIdList": ["11450097"]}, {"Citation": "Shen J., Zhao Z., Shang W., Liu C., Zhang B., Zhao L., et al. (2017). Ginsenoside Rg1 nanoparticle penetrating the blood\u2013brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction. Int. J. Nanomedicine 12 6477\u20136486. 10.2147/IJN.S139602", "ArticleIdList": ["10.2147/IJN.S139602", "PMC5592953", "28919749"]}, {"Citation": "Shi C., Liu J., Wu F., Yew D. T. (2010). Ginkgo biloba extract in Alzheimer\u2019s disease: from action mechanisms to medical practice. Int. J. Mol. Sci. 11 107\u2013123. 10.3390/ijms11010107", "ArticleIdList": ["10.3390/ijms11010107", "PMC2820992", "20162004"]}, {"Citation": "Shinomol G. K., Bharath M. M. (2011). Exploring the role of \u201cBrahmi\u201d(Bacopa monnieri and Centella asiatica) in brain function and therapy. Recent Pat. Endocr. Metab. Immune Drug Discov. 5 33\u201349. 10.2174/187221411794351833", "ArticleIdList": ["10.2174/187221411794351833", "22074576"]}, {"Citation": "Shu X., Zhu K. (2000). A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery. Int. J. Pharm. 201 51\u201358. 10.1016/S0378-5173(00)00403-8", "ArticleIdList": ["10.1016/S0378-5173(00)00403-8", "10867264"]}, {"Citation": "Siemers E. R., Sundell K. L., Carlson C., Case M., Sethuraman G., Liu-Seifert H., et al. (2016). Phase 3 solanezumab trials: secondary outcomes in mild Alzheimer\u2019s disease patients. Alzheimers Dement. 12 110\u2013120. 10.1016/j.jalz.2015.06.1893", "ArticleIdList": ["10.1016/j.jalz.2015.06.1893", "26238576"]}, {"Citation": "Smith A., Giunta B., Bickford P. C., Fountain M., Tan J., Shytle R. D. (2010). Nanolipidic particles improve the bioavailability and \u03b1-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer\u2019s disease. Int. J. Pharm. 389 207\u2013212. 10.1016/j.ijpharm.2010.01.012", "ArticleIdList": ["10.1016/j.ijpharm.2010.01.012", "PMC5831366", "20083179"]}, {"Citation": "Song J.-H., Lee J.-W., Shim B., Lee C.-Y., Choi S., Kang C., et al. (2013). Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice. Molecules 18 15788\u201315803. 10.3390/molecules181215788", "ArticleIdList": ["10.3390/molecules181215788", "PMC6269849", "24352029"]}, {"Citation": "Songjiang Z., Lixiang W. (2009). Amyloid-beta associated with chitosan nano-carrier has favorable immunogenicity and permeates the BBB. AAPS PharmSciTech 10 900\u2013905. 10.1208/s12249-009-9279-1", "ArticleIdList": ["10.1208/s12249-009-9279-1", "PMC2802149", "19609682"]}, {"Citation": "Sperling R. A., Karlawish J., Johnson K. A. (2013). Preclinical Alzheimer disease\u2014the challenges ahead. Nat. Rev. Neurol. 9 54\u201358. 10.1038/nrneurol.2012.241", "ArticleIdList": ["10.1038/nrneurol.2012.241", "PMC3643203", "23183885"]}, {"Citation": "Subash S., Essa M. M., Braidy N., Al-Jabri A., Vaishnav R., Al-Adawi S., et al. (2016). Consumption of fig fruits grown in Oman can improve memory, anxiety, and learning skills in a transgenic mice model of Alzheimer\u2019s disease. Nutr. Neurosci. 19 475\u2013483. 10.1179/1476830514Y.0000000131", "ArticleIdList": ["10.1179/1476830514Y.0000000131", "24938828"]}, {"Citation": "Suganthy N., Ramkumar V. S., Pugazhendhi A., Benelli G., Archunan G. (2017). Biogenic synthesis of gold nanoparticles from Terminalia arjuna bark extract: assessment of safety aspects and neuroprotective potential via antioxidant, anticholinesterase, and antiamyloidogenic effects. Environ. Sci. Pollut. Res. 25 10418\u201310433. 10.1007/s11356-017-9789-4", "ArticleIdList": ["10.1007/s11356-017-9789-4", "28762049"]}, {"Citation": "Sun D., Li N., Zhang W., Zhao Z., Mou Z., Huang D., et al. (2016). Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer\u2019s disease. Colloids Surf. B Biointerfaces 148 116\u2013129. 10.1016/j.colsurfb.2016.08.052", "ArticleIdList": ["10.1016/j.colsurfb.2016.08.052", "27591943"]}, {"Citation": "Tabuchi M., Imamura S., Kawakami Z., Ikarashi Y., Kase Y. (2012). The blood\u2013brain barrier permeability of 18\u03b2-glycyrrhetinic acid, a major metabolite of glycyrrhizin in Glycyrrhiza root, a constituent of the traditional Japanese medicine yokukansan. Cell. Mol. Neurobiol. 32 1139\u20131146. 10.1007/s10571-012-9839-x", "ArticleIdList": ["10.1007/s10571-012-9839-x", "22488528"]}, {"Citation": "Tanifum E. A., Dasgupta I., Srivastava M., Bhavane R. C., Sun L., Berridge J., et al. (2012). Intravenous delivery of targeted liposomes to amyloid-\u03b2 pathology in APP/PSEN1 transgenic mice. PLoS One 7:e48515. 10.1371/journal.pone.0048515", "ArticleIdList": ["10.1371/journal.pone.0048515", "PMC3485335", "23119043"]}, {"Citation": "Tanifum E. A., Ghaghada K., Vollert C., Head E., Eriksen J. L., Annapragada A. (2016). A novel liposomal nanoparticle for the imaging of amyloid plaque by magnetic resonance imaging. J. Alzheimers Dis. 52 731\u2013745. 10.3233/JAD-151124", "ArticleIdList": ["10.3233/JAD-151124", "PMC4931553", "27031484"]}, {"Citation": "Ternchoocheep K., Surangkul D., Ysothonsreekul S. (2017). The recovery and protective effects of asiatic acid on differentiated human neuroblastoma SH-SY5Y cells cytotoxic-induced by cholesterol. Asian Pac. J. Trop. Biomed. 7 416\u2013420. 10.1016/j.apjtb.2017.01.012", "ArticleIdList": ["10.1016/j.apjtb.2017.01.012"]}, {"Citation": "Tiwari S. K., Agarwal S., Seth B., Yadav A., Nair S., Bhatnagar P., et al. (2013). Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer\u2019s disease model via canonical Wnt/\u03b2-catenin pathway. ACS Nano 8 76\u2013103. 10.1021/nn405077y", "ArticleIdList": ["10.1021/nn405077y", "24467380"]}, {"Citation": "Tsai Y.-M., Chien C.-F., Lin L.-C., Tsai T.-H. (2011). Curcumin and its nano-formulation: the kinetics of tissue distribution and blood\u2013brain barrier penetration. Int. J. Pharm. 416 331\u2013338. 10.1016/j.ijpharm.2011.06.030", "ArticleIdList": ["10.1016/j.ijpharm.2011.06.030", "21729743"]}, {"Citation": "Ulbrich K., Hekmatara T., Herbert E., Kreuter J. (2009). Transferrin-and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood\u2013brain barrier (BBB). Eur. J. Pharm. Biopharm. 71 251\u2013256. 10.1016/j.ejpb.2008.08.021", "ArticleIdList": ["10.1016/j.ejpb.2008.08.021", "18805484"]}, {"Citation": "Ullah F., Ayaz M., Sadiq A., Hussain A., Ahmad S., Imran M., et al. (2016). Phenolic, flavonoid contents, anticholinesterase and antioxidant evaluation of Iris germanica var; florentina. Nat. Prod. Res. 30 1440\u20131444. 10.1080/14786419.2015.1057585", "ArticleIdList": ["10.1080/14786419.2015.1057585", "26166432"]}, {"Citation": "Vareed S. K., Bauer A. K., Nair K. M., Liu Y., Jayaprakasam B., Nair M. G. (2014). Blood\u2013brain barrier permeability of bioactive withanamides present in Withania somnifera fruit extract. Phytother. Res. 28 1260\u20131264. 10.1002/ptr.5118", "ArticleIdList": ["10.1002/ptr.5118", "24458838"]}, {"Citation": "Videira R., Castanheira P., Gradddos M. R., Resende R., Salgueiro L., Faro C., et al. (2014). Dose-dependent inhibition of BACE-1 by the monoterpenoid 2, 3, 4, 4-tetramethyl-5-methylenecyclopent-2-enone in cellular and mouse models of Alzheimer\u2019s disease. J. Nat. Prod. 77 1275\u20131279. 10.1021/np400903w", "ArticleIdList": ["10.1021/np400903w", "24921156"]}, {"Citation": "Viola K. L., Sbarboro J., Sureka R., De M., Bicca M. A., Wang J., et al. (2015). Towards non-invasive diagnostic imaging of early-stage Alzheimer\u2019s disease. Nat. Nanotechnol. 10 91\u201398. 10.1038/nnano.2014.254", "ArticleIdList": ["10.1038/nnano.2014.254", "PMC4300856", "25531084"]}, {"Citation": "Vitthal K. U., Pillai M., Kininge P. (2013). Study of solid lipid nanoparticles as a carrier for bacoside. Int. J. Pharma Biosci. 3 414\u2013426."}, {"Citation": "Wang M., Li Y., Ni C., Song G. (2017). Honokiol attenuates oligomeric amyloid \u03b21-42-induced Alzheimer\u2019s disease in mice through attenuating mitochondrial apoptosis and inhibiting the nuclear factor kappa-B signaling pathway. Cell. Physiol. Biochem. 43 69\u201381. 10.1159/000480320", "ArticleIdList": ["10.1159/000480320", "28848085"]}, {"Citation": "Wang X., Chi N., Tang X. (2008). Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur. J. Pharm. Biopharm. 70 735\u2013740. 10.1016/j.ejpb.2008.07.005", "ArticleIdList": ["10.1016/j.ejpb.2008.07.005", "18684400"]}, {"Citation": "Wang X., Duan X., Yang G., Zhang X., Deng L., Zheng H., et al. (2011). Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model. PLoS One 6:e18490. 10.1371/journal.pone.0018490", "ArticleIdList": ["10.1371/journal.pone.0018490", "PMC3084695", "21559510"]}, {"Citation": "Wang Z. H., Wang Z. Y., Sun C. S., Wang C. Y., Jiang T. Y., Wang S. L. (2010). Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain. Biomaterials 31 908\u2013915. 10.1016/j.biomaterials.2009.09.104", "ArticleIdList": ["10.1016/j.biomaterials.2009.09.104", "19853292"]}, {"Citation": "Wilson B., Samanta M. K., Santhi K., Kumar K. P. S., Paramakrishnan N., Suresh B. (2008). Poly (n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer\u2019s disease. Brain Res. 1200 159\u2013168. 10.1016/j.brainres.2008.break01.039", "ArticleIdList": ["10.1016/j.brainres.2008.break01.039", "18291351"]}, {"Citation": "Wilson B., Samanta M. K., Santhi K., Kumar K. S., Ramasamy M., Suresh B. (2010). Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. Nanomedicine 6 144\u2013152. 10.1016/j.nano.2009.04.001", "ArticleIdList": ["10.1016/j.nano.2009.04.001", "19446656"]}, {"Citation": "Winblad B., Jelic V. (2004). Long-term treatment of Alzheimer disease: efficacy and safety of acetylcholinesterase inhibitors. Alzheimer Dis. Assoc. Disord. 18 S2\u2013S8. 10.1097/01.wad.0000127495.10774.a4", "ArticleIdList": ["10.1097/01.wad.0000127495.10774.a4", "15249842"]}, {"Citation": "Wu L., Zhang Q.-L., Zhang X.-Y., Lv C., Li J., Yuan Y., et al. (2012). Pharmacokinetics and blood\u2013brain barrier penetration of (+)-catechin and (-)-epicatechin in rats by microdialysis sampling coupled to high-performance liquid chromatography with chemiluminescence detection. J. Agric. Food Chem. 60 9377\u20139383. 10.1021/jf301787f", "ArticleIdList": ["10.1021/jf301787f", "22953747"]}, {"Citation": "Xie C.-L., Li J.-H., Wang W.-W., Zheng G.-Q., Wang L.-X. (2015). Neuroprotective effect of ginsenoside-Rg1 on cerebral ischemia/reperfusion injury in rats by downregulating protease-activated receptor-1 expression. Life Sci. 121 145\u2013151. 10.1016/j.lfs.2014.12.002", "ArticleIdList": ["10.1016/j.lfs.2014.12.002", "25498890"]}, {"Citation": "Xu Z.-C., Wang X.-B., Yu W.-Y., Xie S.-S., Li S.-Y., Kong L.-Y. (2014). Design, synthesis and biological evaluation of benzylisoquinoline derivatives as multifunctional agents against Alzheimer\u2019s disease. Bioorg. Med. Chem. Lett. 24 2368\u20132373. 10.1016/j.bmcl.2014.03.058", "ArticleIdList": ["10.1016/j.bmcl.2014.03.058", "24726809"]}, {"Citation": "Yang F., Lim G. P., Begum A. N., Ubeda O. J., Simmons M. R., Ambegaokar S. S., et al. (2005). Curcumin inhibits formation of amyloid \u03b2 oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 280 5892\u20135901. 10.1074/jbc.M404751200", "ArticleIdList": ["10.1074/jbc.M404751200", "15590663"]}, {"Citation": "Yerer M. B., Tiryaki M. K., Demirpolat E. (2017). GSK-3beta inhibitory effects of 6-gingerol and 6-shogaol help to the recovery of SHSY-5Y cells after amyloid beta1\u201342 oligomer or aggregate toxicity. J. Cell. Biotechnol. 2 145\u2013157. 10.3233/JCB-15035", "ArticleIdList": ["10.3233/JCB-15035"]}, {"Citation": "Yiannopoulou K. G., Papageorgiou S. G. (2013). Current and future treatments for Alzheimer\u2019s disease. Ther. Adv. Neurol. Disord. 6 19\u201333. 10.1177/1756285612461679", "ArticleIdList": ["10.1177/1756285612461679", "PMC3526946", "23277790"]}, {"Citation": "Yin Z., Yu T., Xu Y. (2015). Preparation of amyloid immuno-nanoparticles as potential MRI contrast agents for Alzheimer\u2019s disease diagnosis. J. Nanosci. Nanotechnol. 15 6429\u20136434. 10.1166/jnn.2015.11296", "ArticleIdList": ["10.1166/jnn.2015.11296", "26716196"]}, {"Citation": "Yoo D. Y., Nam Y., Kim W., Yoo K.-Y., Park J., Lee C. H., et al. (2011). Effects of Ginkgo biloba extract on promotion of neurogenesis in the hippocampal dentate gyrus in C57BL/6 mice. J. Vet. Med. Sci. 73 71\u201376. 10.1292/jvms.10-0294", "ArticleIdList": ["10.1292/jvms.10-0294", "20814173"]}, {"Citation": "Yordanov G. (2012). Poly (alkyl cyanoacrylate) nanoparticles as drug carriers: 33 years later. Bulg. J. Chem. 1 61\u201372."}, {"Citation": "Zenaro E., Pietronigro E., Della Bianca V., Piacentino G., Marongiu L., Budui S., et al. (2015). Neutrophils promote Alzheimer\u2019s disease\u2013like pathology and cognitive decline via LFA-1 integrin. Nat. Med. 21 880\u2013886. 10.1038/nm.3913", "ArticleIdList": ["10.1038/nm.3913", "26214837"]}, {"Citation": "Zhang C., Chen J., Feng C., Shao X., Liu Q., Zhang Q., et al. (2014). Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer\u2019s disease. Int. J. Pharm. 461 192\u2013202. 10.1016/j.ijpharm.2013.11.049", "ArticleIdList": ["10.1016/j.ijpharm.2013.11.049", "24300213"]}, {"Citation": "Zhang J., Zhou X., Yu Q., Yang L., Sun D., Zhou Y., et al. (2014). Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-\u03b2 aggregation and cytotoxicity. ACS Appl. Mater. Interfaces 6 8475\u20138487. 10.1021/am501341u", "ArticleIdList": ["10.1021/am501341u", "24758520"]}, {"Citation": "Zhang P., Liu X., Zhu Y., Chen S., Zhou D., Wang Y. (2013). Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-\u03baB activation and cytokine production of glial cells. Neurosci. Lett. 534 123\u2013127. 10.1016/j.neulet.2012.11.052", "ArticleIdList": ["10.1016/j.neulet.2012.11.052", "23262090"]}, {"Citation": "Zhang X., Fan Z., Jin T. (2017). Crocin protects against cerebral-ischemia-induced damage in aged rats through maintaining the integrity of blood-brain barrier. Restor. Neurol. Neurosci. 35 65\u201375. 10.3233/RNN-160696", "ArticleIdList": ["10.3233/RNN-160696", "28059805"]}, {"Citation": "Zhang Z. J., Cheang L. C. V., Wang M. W., Lee S. M.-Y. (2011). Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish. Int. J. Mol. Med. 27 195\u2013203.", "ArticleIdList": ["21132259"]}, {"Citation": "Zhao J., Lu S., Yu H., Duan S., Zhao J. (2018). Baicalin and ginsenoside Rb1 promote the proliferation and differentiation of neural stem cells in Alzheimer\u2019s disease model rats. Brain Res. 1678 187\u2013194. 10.1016/j.brainres.2017.10.003", "ArticleIdList": ["10.1016/j.brainres.2017.10.003", "29038007"]}, {"Citation": "Zheng Y.-Q., Liu J.-X., Wang J.-N., Xu L. (2007). Effects of crocin on reperfusion-induced oxidative/nitrative injury to cerebral microvessels after global cerebral ischemia. Brain Res. 1138 86\u201394. 10.1016/j.brainres.2006.12.064", "ArticleIdList": ["10.1016/j.brainres.2006.12.064", "17274961"]}, {"Citation": "Zhou Y., Li H.-Q., Lu L., Fu D.-L., Liu A.-J., Li J.-H., et al. (2014). Ginsenoside Rg1 provides neuroprotection against blood brain barrier disruption and neurological injury in a rat model of cerebral ischemia/reperfusion through downregulation of aquaporin 4 expression. Phytomedicine 21 998\u20131003. 10.1016/j.phymed.2013.12.005", "ArticleIdList": ["10.1016/j.phymed.2013.12.005", "24462216"]}, {"Citation": "Zlokovic B. V. (2011). Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat. Rev. Neurosci. 12 723\u2013738. 10.1038/nrn3114", "ArticleIdList": ["10.1038/nrn3114", "PMC4036520", "22048062"]}, {"Citation": "Zohra T., Ovais M., Khalil A. T., Qasim M., Ayaz M., Shinwari Z. K. (2018). Extraction optimization, total phenolic, flavonoid contents, HPLC-DAD analysis and diverse pharmacological evaluations of Dysphania ambrosioides (L.) Mosyakin & Clemants. Nat. Prod. Res. 10.1080/14786419.2018.1437428 [Epub ahead of print].", "ArticleIdList": ["10.1080/14786419.2018.1437428", "29430965"]}]}], "History": [{"Year": "2018", "Month": "4", "Day": "3"}, {"Year": "2018", "Month": "8", "Day": "30"}, {"Year": "2018", "Month": "11", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "9", "Hour": "6", "Minute": "1"}, {"Year": "2018", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["30405389", "PMC6205985", "10.3389/fnagi.2018.00284"]}}]}